Advertisement

Author: Devin Weiss

Salix Pharma at Neutral – Analyst Blog

We recently downgraded Salix Pharmaceuticals, Ltd. (SLXP) to Neutral from Outperform. Salix faced a setback in late July 2012 when the US Food and Drug Administration (FDA) issued a complete response letter (CRL) for the...

Read More

SIGN UP TO NEWSLETTER

Join our mailing list to receive the latest news and updates from our team.